Added to YB: 2017-08-31
Pitch date: 2017-08-31
CRBP:US [bullish]
Corbus Pharmaceuticals Holdings, Inc.
-94.67%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity.
Market Cap
$202.7M
Pitch Price
$216.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.75
P/E
-2.02
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
CORBUS PHARMACEUTICALS HOLDINGS COM CRBP:US
A summary for this pitch has not been created yet.
Read full article (0 min)